Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALE
876
DELISTED
Allete
ALE
| $8.02M | 0.01% |
98,800
+1,600
| +2% | +$132K |
|
|
CCMP
877
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $8.02M | 0.01% |
55,560
+900
| +2% | +$128K |
|
878
Paylocity
PCTY
$8.1B
| $7.97M | 0.01% |
65,950
+1,200
| +2% | +$131K |
|
879
FTI Consulting
FCN
$4.24B
| $7.95M | 0.01% |
71,800
+300
| +0.4% | +$32.8K |
|
880
Crane NXT
CXT
$2.96B
| $7.93M | 0.01% |
264,292
+4,606
| +2% | +$131K |
|
881
Flowers Foods
FLO
$1.6B
| $7.92M | 0.01% |
364,463
+6,400
| +2% | +$139K |
|
|
COR
882
DELISTED
Coresite Realty Corporation
COR
| $7.92M | 0.01% |
70,600
+1,200
| +2% | +$139K |
|
883
Murphy Oil
MUR
$4.99B
| $7.91M | 0.01% |
295,000
-15,400
| -5% | -$353K |
|
884
FNB Corp
FNB
$6.88B
| $7.9M | 0.01% |
621,915
+10,900
| +2% | +$134K |
|
885
Southwest Gas
SWX
$6.67B
| $7.89M | 0.01% |
103,900
+3,400
| +3% | +$276K |
|
|
LHCG
886
DELISTED
LHC Group LLC
LHCG
| $7.89M | 0.01% |
57,266
+1,100
| +2% | +$137K |
|
887
SolarEdge
SEDG
$1.98B
| $7.85M | 0.01% |
82,600
+2,000
| +2% | +$171K |
|
888
Wendy's
WEN
$1.65B
| $7.84M | 0.01% |
353,200
+6,000
| +2% | +$127K |
|
889
Thor Industries
THO
$4.11B
| $7.83M | 0.01% |
105,400
+1,900
| +2% | +$123K |
|
890
Chegg
CHGG
$89.3M
| $7.82M | 0.01% |
206,200
+5,500
| +3% | +$192K |
|
891
B2Gold
BTG
$6.7B
| $7.8M | 0.01% |
1,946,529
+36,900
| +2% | +$130K |
|
|
SGI
892
Somnigroup International
SGI
$14B
| $7.76M | 0.01% |
356,400
+6,000
| +2% | +$125K |
|
893
Sabra Healthcare REIT
SBRA
$5.15B
| $7.74M | 0.01% |
362,841
+25,100
| +7% | +$562K |
|
|
TXNM
894
TXNM Energy Inc
TXNM
$5.91B
| $7.73M | 0.01% |
152,500
+2,600
| +2% | +$131K |
|
895
Valvoline
VVV
$4.31B
| $7.71M | 0.01% |
360,265
+6,200
| +2% | +$137K |
|
|
NUVA
896
DELISTED
NuVasive, Inc.
NUVA
| $7.7M | 0.01% |
99,569
+1,900
| +2% | +$134K |
|
897
Wintrust Financial
WTFC
$11B
| $7.69M | 0.01% |
108,467
+1,800
| +2% | +$120K |
|
898
STAG Industrial
STAG
$7.12B
| $7.68M | 0.01% |
243,400
+6,900
| +3% | +$212K |
|
899
Frontdoor
FTDR
$5.83B
| $7.68M | 0.01% |
162,003
+2,700
| +2% | +$126K |
|
900
New Jersey Resources
NJR
$5.64B
| $7.67M | 0.01% |
172,200
+4,300
| +3% | +$186K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.